Literature DB >> 25877314

[miR-200b suppresses glioma cell invasion by targeting PROM1].

Biao Peng1, Su Hu2, Mingjun Qin2, Dongdong Luo2, Xun Zhang2, Hailin Zhao2.   

Abstract

OBJECTIVE: To explore whether miR-200b suppresses tumor cell invasion by targeting PROM1, thus to reveal the molecular mechanism that miR-200b functions as a tumor suppressor in glioma.
METHODS: PROM1 3'UTR-luciferase vector was constructed and dual-luciferase reporter gene assay was employed to examine the effect of miR-200b on luciferase activity. Human glioblastoma U87 cells were transfected with miR-200b mimics, and next qRT-PCR and Western blotting were performed to detect the expressions of PROM1 mRNA and protein. The effect of PROM1 down-regulation on invasion was observed after PROM1 siRNA were transfected into U87 cells.
RESULTS: The miR-200b bound to the 3'-untranslated region (UTR) of PROM1 and inhibited the luciferase activity. Its luciferase activity was down-regulated by 57.0% (P < 0.01). PROM1 protein and mRNA expressions were significantly down-regulated when miR-200b was overexpressed in the U87 cells (P < 0.05). siRNA-mediated down-regulation of PROM1 suppressed the potential of cell invasion. The invasion ability of SKOV3 cells after transfection with siRNA-PROM1 was significantly lower than that in the negative control cells (P < 0.05).
CONCLUSION: miR-200b may suppress cell invasion by targeting PROM1 in glioma.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25877314

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

1.  Effect of miRNA-200b on the proliferation and apoptosis of cervical cancer cells by targeting RhoA.

Authors:  Lijie He; Jing Wang; Dandan Chang; Dandan Lv; Haina Li; Heqiang Feng
Journal:  Open Med (Wars)       Date:  2020-10-08

Review 2.  The miR-200 family: multiple effects on gliomas.

Authors:  Lilei Peng; Jie Fu; Yang Ming
Journal:  Cancer Manag Res       Date:  2018-07-13       Impact factor: 3.989

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.